Clinical effectiveness of seven-valent pneumococcal conjugate vaccine (Prevenar) against invasive pneumococcal diseases: prospects for children in France
S Black, H Shinefield, R Cohen, D Floret… - Archives de pediatrie …, 2004 - europepmc.org
A seven-valent pneumococcal polysaccharide-CRM197 carrier protein conjugate vaccine
(PNC7V; Prevenar, Wyeth, Paris) targets the serotypes (belonging to serogroups 14, 6, 19 …
(PNC7V; Prevenar, Wyeth, Paris) targets the serotypes (belonging to serogroups 14, 6, 19 …
The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review
TTH Myint, H Madhava, P Balmer, D Christopoulou… - Advances in …, 2013 - Springer
Introduction Streptococcus pneumoniae can cause invasive pneumococcal diseases (IPD),
such as bacteremic pneumonia, bacteremia, meningitis, and sepsis, and non-IPDs, such as …
such as bacteremic pneumonia, bacteremia, meningitis, and sepsis, and non-IPDs, such as …
Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2+ 1 schedule to healthy infants in The Gambia: a single-centre, double …
I Adigweme, A Futa, E Saidy-Jah, B Edem… - The Lancet Infectious …, 2023 - thelancet.com
Background Three pneumococcal conjugate vaccines (PCVs) are currently licensed and
WHO prequalified for supply by UN agencies. Here, we aimed to investigate the safety and …
WHO prequalified for supply by UN agencies. Here, we aimed to investigate the safety and …
Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: a systematic review
JS Ngocho, B Magoma, GA Olomi, MJ Mahande… - PLoS …, 2019 - journals.plos.org
Background Despite the widespread implementation of the pneumococcal conjugate
vaccine, Streptococcus pneumoniae remains the leading cause of severe pneumonia …
vaccine, Streptococcus pneumoniae remains the leading cause of severe pneumonia …
Meta‐analysis of the efficacy of conjugate vaccines against invasive pneumococcal disease
KP Klugman, F Cutts, RA Adegbola… - … vaccines: the impact …, 2008 - Wiley Online Library
This chapter reviews the results of four trials to study efficacy of pneumococcal conjugate
vaccine against invasive pneumococcal disease (IPD) and explores the protection achieved …
vaccine against invasive pneumococcal disease (IPD) and explores the protection achieved …
Heptavalent pneumococcal conjugate vaccine: current and future impact
KK Hsu, SI Pelton - Expert Review of Vaccines, 2003 - Taylor & Francis
Diseases caused by Streptococcus pneumoniae contribute significantly to worldwide
morbidity and mortality. S. pneumoniae is now the number one cause of invasive bacterial …
morbidity and mortality. S. pneumoniae is now the number one cause of invasive bacterial …
Pneumococcal conjugate vaccine and clinically suspected invasive pneumococcal disease
AA Palmu, TM Kilpi, H Rinta-Kokko, H Nohynek… - …, 2015 - publications.aap.org
OBJECTIVE: Ten-valent pneumococcal conjugate vaccine (PCV10) was earlier shown to
reduce clinically suspected, non–laboratory-confirmed invasive pneumococcal disease …
reduce clinically suspected, non–laboratory-confirmed invasive pneumococcal disease …
The antibody response following a booster with either a 10-or 13-valent pneumococcal conjugate vaccine in toddlers primed with a 13-valent pneumococcal …
J Trück, S Jawad, D Goldblatt, L Roalfe… - The Pediatric …, 2016 - journals.lww.com
Background: Both the 13-and 10-valent pneumococcal conjugate vaccines (PCV-13; PCV-
10) are immunogenic and effective against vaccine-type pneumococcal disease when given …
10) are immunogenic and effective against vaccine-type pneumococcal disease when given …
Efficacy of different pneumococcal conjugate vaccine schedules against pneumonia, hospitalisation, and mortality: re-analysis of a randomised trial in The Gambia
Background Pneumococcal conjugate vaccines (PCV) reduce disease due to Streptococcus
pneumoniae. We aimed to determine the efficacy of different PCV schedules in Gambian …
pneumoniae. We aimed to determine the efficacy of different PCV schedules in Gambian …
Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a …
MG Lucero, H Nohynek, G Williams… - The Pediatric …, 2009 - journals.lww.com
Background: Pneumococcus is a leading cause of childhood pneumonia worldwide.
Pneumococcal conjugate vaccines (PCV) have demonstrated efficacy against childhood …
Pneumococcal conjugate vaccines (PCV) have demonstrated efficacy against childhood …